Nxera Pharma Co., Ltd. (TYO:4565)
Japan · Delayed Price · Currency is JPY 1,130.00
+14.00 (1.25%)
Aug 27, 2026, 11:04 AM JST
Nxera Pharma Stock Forecast
Stock Price Forecast
According to 8 analysts polled by S&P Global, Nxera Pharma stock has a consensus rating of "Buy" and an average price target of ¥1,928. The average 1-year stock price forecast is 70.58% higher than the current stock price, while the lowest is ¥1,000 (-11.50%) and the highest is ¥4,500 (+298.23%).
Price Target: ¥1,928 (+70.58%)
Analyst Consensus: Buy
Price Target
ChartAnalyst Ratings
The average analyst rating for Nxera Pharma stock is "Buy". This means that analysts believe this stock is likely to outperform the market over the next twelve months.
Recommendation Trends
| Rating | Mar '26 | Apr '26 | May '26 | Jun '26 | Jul '26 | Aug '26 |
|---|---|---|---|---|---|---|
| Strong Buy | 5 | 5 | 5 | 5 | 5 | 5 |
| Buy | 1 | 1 | 1 | 1 | 1 | 1 |
| Hold | 2 | 2 | 2 | 2 | 2 | 2 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 8 | 8 | 8 | 8 | 8 | 8 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
Unknown Analyst Citi No rating | Citi | Buy Maintains ¥1,500 → ¥2,000 | Buy | Maintains | ¥1,500 → ¥2,000 | +76.99% | Aug 13, 2026 |
Financial Forecast
Revenue This Year
40.16B
from 29.62B
Increased by 35.59%
Revenue Next Year
40.08B
from 40.16B
Decreased by -0.20%
EPS This Year
n/a
EPS Next Year
n/a
Financial currency is JPY.